Results 1 to 10 of about 914,168 (204)

Rift valley fever (RVF) viral zoonotic disease steadily circulates in the Mauritanian animals and humans: A narrative review [PDF]

Health Science Reports, 2023
AbstractBackground and AimRift valley fever (RVF) virus (RVFV) is reportedly steadily circulating in Mauritania being repeated in 1987, 2010, 2012, 2015, and 2020. Mauritania seems a preferred niche for RVF virus due to its persistent outbreak there. Lately, nine Mauritanian wilayas confirmed 47 (23 fatalities with 49% CFR) human cases between August ...
Ranjan K Mohapatra, Ranjit Sah, Bijaya Kumar Padhi   +2 more
exaly   +5 more sources

Goat seropositivity as an indicator of Rift Valley fever (RVF) infection in human populations: A case-control study of the 2018 Rift Valley fever outbreak in Wajir County, Kenya [PDF]

One Health
Rift Valley fever (RVF) is a viral zoonosis, which is considered as a threat to food security in the Horn of Africa. In Kenya, RVF is the 5th ranked priority zoonotic disease due to its high morbidity and mortality, frequent outbreak events, and associated socioeconomic impacts during outbreak events.
Omani R, Cavalerie L, Daud A, Cook EAJ, Nakadio E, Fèvre EM, Gitao G, Robinson J, Nanyingi M, Baylis M, Kimeli P, Onono J.   +11 more
exaly   +5 more sources

Theoretical risk of genetic reassortment should not impede development of live, attenuated Rift Valley fever (RVF) vaccines commentary on the draft WHO RVF Target Product Profile [PDF]

Vaccine: X, 2020
In November 2019, The World Health Organization (WHO) issued a draft set of Target Product Profiles (TPPs) describing optimal and minimally acceptable targets for vaccines against Rift Valley fever (RVF), a Phlebovirus with a three segmented genome, in both humans and ruminants.
Brian H Bird, Angelle Desiree LaBeaud, Darci R Smith   +2 more
exaly   +6 more sources

The Pathogenesis of Rift Valley Fever

Viruses, 2011
Rift Valley fever (RVF) is an emerging zoonotic disease distributed in sub-Saharan African countries and the Arabian Peninsula. The disease is caused by the Rift Valley fever virus (RVFV) of the family Bunyaviridae and the genus Phlebovirus. The virus is
Tetsuro Ikegami, Shinji Makino
exaly   +4 more sources

Survey of Rift Valley Fever Virus Antibodies and Risk Factors in Small Ruminants in Maiduguri, Borno State, Nigeria: A Cross-Sectional Serological Study. [PDF]

Vet Med Sci
High seroprevalence of Rift Valley fever virus antibodies (47.9%) in small ruminants in Maiduguri indicates substantial past exposure. Age, sex, and residence in flood‐prone areas were significant risk factors, highlighting the need for targeted surveillance and vector control to reduce livestock and public health impacts.
Mohammed S, Mohammed A, Saidu AS, Gashua MM, Adamu SG, Yusuf IM, Jigbin D, Tijani AO, Musa HI.   +8 more
europepmc   +2 more sources

An Overview of Rift Valley Fever Vaccine Development Strategies

Vaccines, 2022
Rift Valley fever (RVF) is a mosquito-borne viral zoonosis that causes high fetal and neonatal mortality in ruminants and a mild to fatal hemorrhagic fever in humans.
Paul F McKay, Robin Shattock, Paul Kitandwe   +2 more
exaly   +3 more sources

Entropy-based analysis of Rift Valley fever transmission dynamics using delay differential equations. [PDF]

PLoS ONE
Rift Valley Fever (RVF) is a vector-borne, transmissible zoonotic disease in animals and humans caused by RVF virus and transmitted primarily by mosquitoes and biting flies.
Ali Raza, Mansoor Alsulami, Marek Lampart, Umar Shafique, Eman Ghareeb Rezk   +4 more
doaj   +2 more sources

The Rift Valley fever (RVF) vaccine candidate 40Fp8 shows an extreme attenuation in IFNARKO mice following intranasal inoculation. [PDF]

PLoS Negl Trop Dis
Abstract Rift Valley fever (RVF) is an important zoonotic viral disease affecting several species of domestic and wild ruminants, causing major economic losses and dozens of human deaths in various geographical areas of Africa, where it is endemic.
Borrego B, Alonso C, Moreno S, de la Losa N, Sánchez-Cordón PJ, Brun A.   +5 more
europepmc   +5 more sources

Development of Rift Valley fever (RVF) vaccine by genetic joining of the RVF-glycoprotein Gn with the strong adjuvant subunit B of cholera toxin (CTB) and expression in bacterial system. [PDF]

Saudi J Biol Sci, 2019
One of the mosquito-borne zoonotic diseases is the Rift Valley fever virus (RVFV). Currently, there is no completely licensed vaccine that can be used to vaccinate animals or humans outside endemic areas. The aim of this work was to use the RVFV glycoprotein (Gn) and the subunit B of cholera toxin (CTB) at gene level and build up fused recombinant ...
Ibrahim EH, Taha R, Ghramh HA, Kilany M.
europepmc   +3 more sources

Rift Valley fever (RVF): a re-emerging zoonotic disease, pathogenesis, epidemiology, current status, and future perspective - correspondence. [PDF]

Int J Surg, 2023
Akash S, Islam MR, Rahman MM, Rahman MM.
europepmc   +3 more sources